EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 216 filers reported holding EDITAS MEDICINE INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,425,738 | +12.4% | 3,259,710 | +18.6% | 0.30% | +11.2% |
| Q2 2023 | $22,626,780 | +17.9% | 2,749,305 | +3.9% | 0.27% | +2.7% |
| Q1 2023 | $19,187,995 | +4.1% | 2,646,620 | +27.3% | 0.26% | +5.7% |
| Q4 2022 | $18,438,495 | +53.3% | 2,078,748 | +104.4% | 0.25% | +33.5% |
| Q2 2022 | $12,030,000 | +2665.5% | 1,016,891 | +4346.2% | 0.18% | +2542.9% |
| Q1 2022 | $435,000 | – | 22,871 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |